Generation of normal induced pluripotent stem cell line KUMCi002-A from bone marrow CD34+ cells of patient with multiple myeloma disease having 13q deletion and IGH translocation

Seung Jin Lee, Ji Hea Kim, Ka Won Kang, Byung Hyun Lee, Byung Soo Kim

    Research output: Contribution to journalArticlepeer-review

    5 Citations (Scopus)

    Abstract

    Multiple myeloma (MM) is a hematological cancer characterized by an uncontrolled proliferation of antibody-secreting plasma cells within the bone marrow. Currently, cell therapy such as chimeric antigen receptor T-cell (CAR-T) based on induced pluripotent stem cells (iPSCs) has received attention for treating MM. However, the generation of iPSCs from MM patients appears to be very rarely reported. Here we generated an iPSC line from CD34+ bone marrow cells of a patient with MM using human placenta-derived cell conditioned medium (hPCCM), offering a relatively high efficiency in humanized conditions. This iPSC line might be a useful model for research on MM.

    Original languageEnglish
    Article number102030
    JournalStem Cell Research
    Volume49
    DOIs
    Publication statusPublished - 2020 Dec

    Bibliographical note

    Publisher Copyright:
    © 2020 The Author(s)

    ASJC Scopus subject areas

    • Developmental Biology
    • Cell Biology

    Fingerprint

    Dive into the research topics of 'Generation of normal induced pluripotent stem cell line KUMCi002-A from bone marrow CD34+ cells of patient with multiple myeloma disease having 13q deletion and IGH translocation'. Together they form a unique fingerprint.

    Cite this